Remote monitoring of heart failure: benefits for therapeutic decision making

References

• Roth GA, Forouzanfar MH, Moran AE, et al. Demographic and epidemiologic drivers of global cardiovascular mortality. N Engl J Med. 2015;372:1333–1341.
   PubMed Web of Science ®Google Scholar
• Ma J, Ward EM, Siegel RL, et al. Temporal trends in mortality in the United States, 1969-2013. Jama. 2015;314(16):1731–1739.
   PubMed Web of Science ®Google Scholar
• Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–2200.
   PubMed Web of Science ®Google Scholar
• Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart. 2007;93:1137–1146.
   PubMed Web of Science ®Google Scholar
• Redfield MM, Jacobsen SJ, Burnett JC, et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. Jama. 2003;289:194–202.
   PubMed Web of Science ®Google Scholar
• Bleumink GS, Knetsch AM, Sturkenboom MCJM, et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. Eur Heart J England. 2004;25:1614–1619.
   PubMed Web of Science ®Google Scholar
• Ceia F, Fonseca C, Mota T, et al. Prevalence of chronic heart failure in Southwestern Europe: the EPICA study. Eur J Heart Fail. 2002;4:531–539.
   PubMed Web of Science ®Google Scholar
• Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002;347:1397–1402.
   PubMed Web of Science ®Google Scholar
• Roger VL, Weston SA, Redfield MM, et al. Trends in heart failure incidence and survival in a community-based population. Jama. 2004;292:344–350.
   PubMed Web of Science ®Google Scholar
• Mozaffarian D, Anker SD, Anand I, et al. Prediction of mode of death in heart failure: the Seattle heart failure model. Circulation. 2007 Jul 24;116(4):392–398.
   PubMed Web of Science ®Google Scholar
• Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316:1429–1435.
   PubMed Web of Science ®Google Scholar
• MacIntyre K, Capewell S, Stewart S, et al. Evidence of improving prognosis in heart failure: trends in case fatality in 66 547 patients hospitalized between 1986 and 1995. Circulation. 2000;102:1126–1131.
   PubMed Web of Science ®Google Scholar
• Rosamond W, Fleqal K, Friday G, et al. Heart disease and stroke statistics–2007 update: a report from the American heart association statistics committee and stroke statistics subcommittee. Circulation. 2007;115(5):e69–e171.
   PubMed Web of Science ®Google Scholar
• Thom T, Haase N, Rosamond W, et al. Heart disease and stroke statistics–2006 update: a report from the American heart association statistics committee and stroke statistics subcommittee. Circulation. 2006;113:e85– e151.
   PubMed Web of Science ®Google Scholar
• Desai AS, Stevenson LW. Rehospitalization for heart failure. Predict of prevent. Circulation. 2012;126:501–506.
   PubMed Web of Science ®Google Scholar
• Krumholz HM, Merrill AR, Schone EM, et al. Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission. Circ Cardiovasc Qual Outcomes. 2009;2:407–413.
   PubMed Web of Science ®Google Scholar
• Joynt KE, Jha AK. Who has higher readmission rates for heart failure, and why? Implications for efforts to improve care using financial incentives. Circ Cardiovasc Qual Outcomes. 2011;4:53–59.
   PubMed Web of Science ®Google Scholar
• Chun S, Tu JV, Wijeysundera HC, et al. Lifetime analysis of hospitalizations and survival of patients newly-admitted with heart failure. Circ Heart Fail. 2012 May 2. DOI:10.1161/CIRCHEARTFAILURE.111.964791
   PubMed Web of Science ®Google Scholar
• Krumholz HM, Merrill AR, Schone EM, et al. Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission. Circ Cardiovasc Qual Outcomes. 2009;2:407–413.
   PubMed Web of Science ®Google Scholar
• Martirosyan M, Theuns DAMJ, Szili-Torok T. Current Approach to Heart Failure. In: Dorobanţu, Maria, Ruschitzka, Frank, Metra, Marco (Eds.), Chapter 13. Devices for heart failure: implantable cardioverter defibrillator. Switzerland: Springer International Publishing. December 2016. 10.1007/978-3-319-45237-1_13
   Google Scholar
• McKee PA, Castelli WP, McNamara PM, et al. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971;285:1441–1446.
   PubMed Web of Science ®Google Scholar
• Ees VR, Hoes AW, Limburg A, et al. Prevalence of unrecognized heart failure in older persons with shortness of breath on exertion. Eur J Heart Fail. 2014;16:772–777.
   PubMed Web of Science ®Google Scholar
• Gerber Y, Weston SA, Redfield MM, et al. A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010. JAMA Intern Med. 2015;175(6):996–1004.
   PubMed Web of Science ®Google Scholar
• Laribi S, Aouba A, Nikolaou M, et al. Trends in death attributed to heart failure over the past two decades in Europe. Eur J Heart Fail. 2012;14:234–239.
   PubMed Web of Science ®Google Scholar
• Barr DA. Geography as disparity: the shifting burden of heart disease. Circulation. 2016;133:1151–1154.
   PubMed Web of Science ®Google Scholar
• Mosterd A, Cost B, Hoes AW, et al. The prognosis of heart failure in the general population: the Rotterdam study. Eur Heart J. 2001;22:1318–1327.
   PubMed Web of Science ®Google Scholar
• Cowie MR, Wood DA, Coats AJ, et al. Survival of patients with a new diagnosis of heart failure: a population based study. Heart. 2000;83:505–510.
   PubMed Web of Science ®Google Scholar
• Roger VL, Weston SA, Redfield MM, et al. Trends in heart failure incidence and survival in a community-based population. Jama. 2004;292:344–350.
   PubMed Web of Science ®Google Scholar
• Kannel WB. Incidence and epidemiology of heart failure. Heart Fail Rev. 2000;5(2):167–173.
   PubMedGoogle Scholar
• Levy D, Kenchaiah S, Larson MG, et al. Long-term trends in the incidence of and survival with heart failure. N Engl J Med. 2002;347:1397–1402.
   PubMed Web of Science ®Google Scholar
• Chugh SS, Reinier K, Teodorescu C, et al. Epidemiology of sudden cardiac death: clinical and research implications. Prog Cardiovasc Dis. 2008;51:213–228.
   PubMed Web of Science ®Google Scholar
• McCullough PA, Philbin EF, Spertus JA, et al. Resource Utilization Among Congestive Heart Failure (REACH) study. confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. J Am Coll Cardiol. 2002;39:60–69.
   PubMed Web of Science ®Google Scholar
• Ross JS, Chen J, Lin Z, et al. Recent national trends in readmission rates after heart failure hospitalization. Circulation. 2010;3:97–103.
   PubMed Web of Science ®Google Scholar
• Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics–2008 update: a report from the American heart association statistics committee and stroke statistics subcommittee. Circulation. 2008;117:e25–e146.
   PubMed Web of Science ®Google Scholar
• Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European society of cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J. 2008 Oct;29(19):2388–2442.
   PubMed Web of Science ®Google Scholar
• Lindenauer PK, Remus D, Roman S, et al. Public reporting and pay for performance in hospital quality improvement. N Engl J Med. 2007;356:486–496.
   PubMed Web of Science ®Google Scholar
• Hunt SA. American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2005 Sep 20;46(6):e1–82.
   PubMed Web of Science ®Google Scholar
• Klersy C, De Silvestri A, Gabutti G, et al. A meta-analysis of remote monitoring of heart failure patients. J Am Coll Cardiol. 2009 Oct 27;54(18):1683–1694.
   PubMed Web of Science ®Google Scholar
• Mond HG, Proclemer MD. The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009–A world society of Arrhythmia’s project. Pacing Clin Electrophysiol. 2011;34(8):1013–1027.
   PubMed Web of Science ®Google Scholar
• Wilkoff BL, Love CJ, Byrd CL, et al. Heart Rhythm Society expert consensus on facilities, training, indications, and patient management. Heart Rhythm. 2009;6:1085–1104.
   PubMed Web of Science ®Google Scholar
• Theuns DAMJ, Jordaens L. Use of remote monitoring in the management of system-related complications in implantable defibrillator patients. Neth Heart J. 2012;20:82–85.
   PubMed Web of Science ®Google Scholar
• Simon S, HartCarole L, HoleDavid J, et al. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med. 2002;113(5):359–364.
   PubMed Web of Science ®Google Scholar
• Wattigney Wendy A, MensahGeorge A, CroftJanet B. Increased atrial fibrillation mortality: united States, 1980-1998. Am J Epidemiol. 2002;155(9):819–826.
   PubMed Web of Science ®Google Scholar
• Wang Thomas J, LarsonMartin G, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham heart study. Circulation. 2003;107(23):2920–2925.
   PubMed Web of Science ®Google Scholar
• E J B, WolfP A, D’AgostinoR B, et al. Impact of atrial fibrillation on the risk of death: the Framingham heart study. Circulation. 1998;98(10):946–952.
   PubMed Web of Science ®Google Scholar
• Krahn AD, Manfreda J, Tate RB, et al. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba follow- up study. Am J Med. 1995;98(5):476–484.
   PubMed Web of Science ®Google Scholar
• Bunch TJ, Day JD, Olshansky B, et al. Newly detected atrial fibrillation in patients with an implantable cardioverter-defibrillator is a strong risk marker of increased mortality. Heart Rhythm. 2009;6(1):2–8.
   PubMed Web of Science ®Google Scholar
• Caldwell Jane C, Hussain C, Sanjiv P, et al. Atrial fibrillation is under-recognized in chronic heart failure: insights from a heart failure cohort treated with cardiac resynchronization therapy. Europace. 2009;11(10):1295–1300.
   PubMed Web of Science ®Google Scholar
• Inglis SC, Clark RA, Dierckx R, et al. Structured telephone support or non-invasive telemonitoring for patients with heart failure. Cochrane Database Syst Rev. 2015 Oct 31;10:CD007228.
   Google Scholar
• Chaudhry SI, Mattera JA, Curtis JP, et al. Telemonitoring in patients with heart failure. N Engl J Med. 2010;363:2301–2309.
   PubMed Web of Science ®Google Scholar
• Koehler F, Winkler S, Schieber M, et al. Telemedical Interventional Monitoring in Heart Failure (TIM-HF), a randomized, controlled intervention trial investigating the impact of telemedicine on mortality in ambulatory patients with heart failure: study design. Eur J Heart Fail. 2010;12:1354–1362.
   PubMed Web of Science ®Google Scholar
• Angermann CE, Stork S, Gelbrich G, et al. Mode of action and effects of standardized collaborative disease management on mortality and mobidity in patient with systolic heart failure. Circ Heart Fail. 2012;5:25–35.
   PubMed Web of Science ®Google Scholar
• Lyng P, Persson H, Hgg-Martinell A, et al. Weight monitoring in patients with severe heart failure (WISH). A randomized controlled trial. Eur J Heart Fail. 2012;14:438–444.
   PubMed Web of Science ®Google Scholar
• Boyne JJJ, Vrijhoef HJM, Crijns HJGM, et al. Tailored telemonitoring in patients with heart failure: results of a multicentre randomized controlled trial. Eur J Heart Fail. 2012;14:791–801.
   PubMed Web of Science ®Google Scholar
• Wilkoff BL, Auricchio A, Brugada J, et al. HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations: developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA); and in collaboration with the American College of Cardiology (ACC), the American Heart Association (AHA), the European Society of Cardiology (ESC), the Heart Failure Association of ESC (HFA), and the Heart Failure Society of America (HFSA): endorsed by the Heart Rhythm Society, the European Heart Rhythm Association (a registered branch of the ESC), the American College of Cardiology, the American Heart Association. Europace. 2008;10:707–725.
   PubMed Web of Science ®Google Scholar
• Middlekauff HR, Stevenson WG, Stevenson LW. Prognostic significance of atrial fibrillation in advanced heart failure: a study of 390 patients. Circulation. 1991;84:40–48.
   PubMed Web of Science ®Google Scholar
• Carson PE, Johnson GR, Dunkman WB, et al. The influence of atrial fibrillation on prognosis in mild to moderate heart failure: the V-HeFT studies: the V-HeFT VA cooperative studies group. Circulation. 1993;87(suppl):VI-102–VI-110.
   Google Scholar
• Mahoney P, Kimmel S, DeNofrio D, et al. Prognostic significance of atrial fibrillation in patients at a tertiary medical center referred for heart transplantation because of severe heart failure. Am J Cardiol. 1999;83:1544–1547.
   PubMed Web of Science ®Google Scholar
• Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation. 1998;98:2282–2289.
   PubMed Web of Science ®Google Scholar
• Deedwania PC, Singh BN, Ellenbogen K, et al. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the Veterans Affairs Congestive Heart Failure Survival Trial of Antiarrhythmic Therapy (CHF-STAT): the Department of Veterans Affairs CHF-STAT Investigators. Circulation. 1998;98:2574–2579.
   PubMed Web of Science ®Google Scholar
• Healey Jeff S, Connolly Stuart J, Gold Michael R, et al. Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012;366(2):120–129.
   PubMed Web of Science ®Google Scholar
• Ziegler Paul D, Glotzer Taya V, Daoud Emile G, et al. Detection of previously undiagnosed atrial fibrillation in patients with stroke risk factors and usefulness of continuous monitoring in primary stroke prevention. Am J Cardiol. 2012;110(9):1309–1314.
   PubMed Web of Science ®Google Scholar
• Glotzer Taya V, Hellkamp Anne S, John Z, et al. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). Circulation. 2003;107(12):1614–1619.
   PubMed Web of Science ®Google Scholar
• Nesan S, Annegret B, Jochen P, et al. Detection of atrial high-rate events by continuous home monitoring: clinical significance in the heart failure-cardiac resynchronization therapy population. Europace. 2012;14(2):230–237.
   PubMed Web of Science ®Google Scholar
• Ricci RP, Morichelli L, Santini M. Remote control of implanted devices through Home Monitoring technology improves detection and clinical management of atrial fibrillation. Europace. 2009;11(1):54–61.
   PubMed Web of Science ®Google Scholar
• Arnaud L. Remote, wireless, ambulatory monitoring of implantable pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy systems: analysis of a worldwide database. Pacing Clin Electrophysiol. 2007;30(Suppl 1):S2–S12.
   PubMed Web of Science ®Google Scholar
• Niraj V, Epstein Andrew E, Anand I, et al. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T safely reduces routine office device follow-up (TRUST) trial. Circulation. 2010;122(4):325–332.
   PubMed Web of Science ®Google Scholar
• Crossley George H, Andrew B, Holly V, et al. The CONNECT (Clinical Evaluation of Remote Notification to Reduce Time to Clinical Decision) trial: the value of wireless remote monitoring with automatic clinician alerts. J Am Coll Cardiol. 2011;57(10):1181–1189.
   PubMed Web of Science ®Google Scholar
• Ricci RP, Morichelli L, Gargaro A, et al. Home monitoring in patients with implantable cardiac devices: is there a potential reduction of stroke risk? Results from a computer model tested through monte carlo simulations. J Cardiovasc Electrophysiol. 2009;20(11):1244–1251.
   PubMed Web of Science ®Google Scholar
• Philippe M, Frédéric V, Patrick B, et al. A randomized trial of long-term remote monitoring of pacemaker recipients (the COMPAS trial). Eur Heart J. 2012;33(9):1105–1111.
   PubMed Web of Science ®Google Scholar
• Martin David T, BersohnMalcolm M, WaldoAlbert L, et al. Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices. Eur Heart J. 2015;36(26):1660–1668.
   PubMed Web of Science ®Google Scholar
• Aronson D, Mittleman MA, Burger AJ, et al. Measures of heart period variability as predictors of mortality in hospitalized patients with decompensated congestive heart failure. Am J Cardiol. 2004;93(1):59–63.
   PubMed Web of Science ®Google Scholar
• Adamson PB, Smith AL, Abraham WT, et al. Continuous autonomic assessment in patients with symptomatic heart failure: prognostic value of heart rate variability measured by an implanted cardiac resynchronization device. Circulation. 2004;110:2389–2394.
   PubMed Web of Science ®Google Scholar
• Kleemann T, Becker T, Doenges K, et al. Annual rate of transvenous defirbillation lead defects in implantable cardioverter-defirbillators over a period of >10 years. Circulation. 2008;118:2122–2129.
   PubMed Web of Science ®Google Scholar
• Nielsen JC, Kottkamp H, Zabel M, et al. Automatic home monitoring of implantable cardioverter defibrillators. Europace. 2008;10:729–735.
   PubMed Web of Science ®Google Scholar
• Hauck M, Bauer A, Voss F, et al. “Home monitoring” for early detection of implantable cardioverter-defibrillator failure: a single-center prospective observational study. Clin Res Cardiol. 2009;98:19–24.
   PubMed Web of Science ®Google Scholar
• Theuns DA, Rivero-Ayerza M, Knops P, et al. Analysis of 57,148 transmissions by remote monitoring of implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2009;32(Suppl 1):S63–5.
   PubMed Web of Science ®Google Scholar
• De Ruvo E, Gargaro A, Sciarra L, et al. Early detection of adverse events with daily remote monitoring versus quarterly standard follow-up program in patients with CRT-D. Pacing Clin Electrophysiol. 2010;34:208–216.
   PubMed Web of Science ®Google Scholar
• Al-Khatib SM, Piccini JP, Knight D, et al. Remote monitoring of implantable cardioverter defibrillators versus quarterly device interrogations in clinic: results from a randomized pilot clinical trial. J Cardiovasc Electrophysiol. 2010;21:545–550.
   PubMed Web of Science ®Google Scholar
• Guedon-Moreau L, Chevalier P, Marquie C, et al. Contributions of remote monitoring to the follow-up of implantable cardioverter-defibrillator leads under advisory. Eur Heart J. 2010;31:2246–2252.
   PubMed Web of Science ®Google Scholar
• Varma N, Michalski J, Epstein AE, et al. Automatic remote monitoring of implantable cardioverter-defibrillator lead and generator performance: the Lumos-T Safely RedUceS RouTine Office Device Follow-Up (TRUST) trial. Circ Arrhythm Electrophysiol. 2010;3:428–436.
   PubMed Web of Science ®Google Scholar
• Folino AF, Chiusso F, Zanotto G, et al. Management of alert messages in the remote monitoring of implantable cardioverter defibrillators and pacemakers: an Italian single-region study. Europace. 2011;13:1281–1291.
   PubMed Web of Science ®Google Scholar
• Varma N, Epstein AE, Iripmen A, et al. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation. 2010;122:325–332.
   PubMed Web of Science ®Google Scholar
• Spencker S, Coban N, Koch L, et al. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure. Europace. 2009;11(4):483–488.
   PubMed Web of Science ®Google Scholar
• Yu CM, Wang L, Chau E, et al. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation. 2005;112:841–848.
   PubMed Web of Science ®Google Scholar
• Abraham WT, Compton S, Haas G, et al. Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the Fluid Accumulation Status Trial (FAST). Congest Heart Fail. 2011;17:51–55.
   PubMedGoogle Scholar
• Ypenburg C, Bax JJ, van der Wall EE, et al. Intrathoracic impedance monitoring to predict decompensated heart failure. Am J Cardiol. 2007;99:554–557.
   PubMed Web of Science ®Google Scholar
• Conraads VM, Tavazzi L, Santini M, et al. Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial. Eur Heart J. 2011;32:2266–2273.
   PubMed Web of Science ®Google Scholar
• Van Veldhuisen DJ, Braunschweig F, Conraads V, et al. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circulation. 2011;124:1719–1726.
   PubMed Web of Science ®Google Scholar
• Whellan DJ, Ousdigin KT, Al-Khatib SM, et al. PARTNERS Study Investigators. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. J Am Coll Cardiol. 2010;55(17):1803–1810.
   PubMed Web of Science ®Google Scholar
• Cowie MR, Sarkar S, Koehler J, et al. Development and validation of an integrated diagnostic algorithm derived from parameters monitored in implantable devices for identifying patients at risk for heart failure hospitalization in an ambulatory setting. Eur Heart J. 2013;34(31):2472–2480.
   PubMed Web of Science ®Google Scholar
• Hindriks G, Taborsky M, Glikson M, et al. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. The Lancet. 2014 August 16-22;384(9943):583–590.
   PubMed Web of Science ®Google Scholar
• https://www.escardio.org/The-ESC/Press-Office/Press-releases/the-rem-hf-trial-remote-monitoring-of-implantable-cardiac-devices-no-added-bene
   Google Scholar
• Boriani G, Da Costa A, Quesada A, et al. Effects of remote monitoring on clinical outcomes and use of healthcare resources in heart failure patients with biventricular defibrillators: results of the MORE-CARE multicentre randomized controlled trial. Eur J Heart Fail. 2017;19(3):416–425.
   Web of Science ®Google Scholar
• https://cardiacrhythmnews.com/remote-monitoring-for-heart-failure-may-not-improve-clinical-outcomes/.
   Google Scholar
• Parati G, Lombardi C, Castagna F, et al. Heart failure and sleep disorders. Nat Rev Cardiol. 2016 Jul;13(7):389–403.
   PubMed Web of Science ®Google Scholar
• Hayes D Jr., Anstead MI, Ho J, et al. Insomnia and chronic heart failure. Heart Fail Rev. 2009;14:171–182.
   PubMed Web of Science ®Google Scholar
• Jimenez JA, Greenberg BH, Mills PJ. Effects of heart failure and its pharmacological management on sleep. Drug Discov Today Dis Models. 2011;8:161–166.
   PubMedGoogle Scholar
• Arzt M, Woehrle H, Oldenburg O, et al. Prevalence and predictors of sleep-disordered breathing in patients with stable chronic heart failure: the SchlaHF Registry. JACC Heart Fail. 2016;4:116–125.
   PubMed Web of Science ®Google Scholar
• Bitter T, Faber L. Herinq D, Lanqer C, et al. Sleep-disordered breathing in heart failure with normal left ventricular ejection fraction. Eur J Heart Fail. 2009;11:602–608.
   PubMed Web of Science ®Google Scholar
• Eisenberg E, Zimlichman R, Lavie P. Plasma norepinephrine levels in patients with sleep apnea syndrome. N Engl J Med. 1990;322:932–933.
   PubMed Web of Science ®Google Scholar
• Thomas JA, Marks BH. Plasma norepinephrine in congestive heart failure. Am J Cardiol. 1978;41:233–243.
   PubMed Web of Science ®Google Scholar
• Spaak J, Eqri ZJ, Kubo T, et al. Muscle sympathetic nerve activity during wakefulness in heart failure patients with and without sleep apnea. Hypertension. 2005;46:1327–1332.
   PubMed Web of Science ®Google Scholar
• Franklin KA, Nilsson JB, Sahlin C, et al. Sleep apnoea and nocturnal angina. Lancet. 1995;345:1085–1087.
   PubMed Web of Science ®Google Scholar
• Tkacova R, Dajani HR, Rankin F, et al. Continuous positive airway pressure improves nocturnal baroreflex sensitivity of patients with heart failure and obstructive sleep apnea. J Hypertens. 2000;18:1257–1262.
   PubMed Web of Science ®Google Scholar
• Malone S, Liu PP, Holloway R, et al. Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure. Lancet. 1991;338:1480–1484.
   PubMed Web of Science ®Google Scholar
• Kauta SR, Keenan BT, Goldberg L, et al. Diagnosis and treatment of sleep disordered breathing in hospitalized cardiac patients: a reduction in 30-day hospital readmission rates. J Clin Sleep Med. 2014;10:1051–1059.
   PubMed Web of Science ®Google Scholar
• Kaneko Y, Floras JS, Usui K, et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med. 2003;348:1233–1241.
   PubMed Web of Science ®Google Scholar
• Mansfield DR, Gollogly NC, Kaye DM, et al. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med. 2004;169:361–366.
   PubMed Web of Science ®Google Scholar
• Sun H, Shi J, Li M, et al. Impact of continuous positive airway pressure treatment on left ventricular ejection fraction in patients with obstructive sleep apnea: a meta-analysis of randomized controlled trials. PLoS ONE. 2013;8:e62298.
   PubMed Web of Science ®Google Scholar
• Somers VK, White DP, Amin R, et al. American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology; American Heart Association Stroke Council; American Heart Association Council on Cardiovascular Nursing; American College of Cardiology Foundation. Circulation. 2008;118:1080–1111.
   PubMed Web of Science ®Google Scholar
• Defaye P, De La Cruz I, Marti-Almor J, et al. A pacemaker transthoracic impedance sensor with an advanced algorithm to identify severe sleep apnea: the DREAM European study. Heart Rhythm. 2014 May;11(5):842–848.
   PubMed Web of Science ®Google Scholar
• Kuck KH, Bordachar P, Borggrefe M, et al. New devices in heart failure: an European Heart Rhythm Association report. Developed by the European Heart Rhythm Association; Endorsed by the Heart Failure Association. Europace. 2014;16:109–128.
   PubMed Web of Science ®Google Scholar
• Bourge RC, Abraham WT, Adamson PB, et al. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J Am Coll Cardiol. 2008;51(11):1073–1079.
   PubMed Web of Science ®Google Scholar
• Adamson PB, Gold MR, Bennett T, et al. Continuous hemodynamic monitoring in patients with mild to moderate heart failure: results of The Reducing Desompensation Events Utilizing Intracardiac Pressures in Patients with Chronic Heart Failure (REDUCEhf) trial. Congest Heart Fail. 2011;17:248–254.
   PubMedGoogle Scholar
• Abraham WT, Adamson PB, Hasan A, et al. Safety and accuracy of a wireless pulmonary artery pressure monitoring system in patients with heart failure. Am Heart J. 2011;161:558–566.
   PubMed Web of Science ®Google Scholar
• Ritzema J, Troughton R, Melton I, et al. Physician-directed patient self-management of the left atrial pressure on advanced chronic heart failure. Circulation. 2010;121(9):1086–1095.
   PubMed Web of Science ®Google Scholar